Prime Medicine, Inc. - Common Stock — Liquidità (NASDAQ:PRME)

Financials

Panoramica Estratto Conto Statistiche Dividendi

Flusso di cassa derivante dalle attività operative -131.83 M-165.41 M-122.86 M-162.56 M -156.42 M Flussi di cassa derivanti dalle attività di investimento -47.1 M18.71 M68.46 M-108.76 M -17.63 M Liquidità derivante dalle attività di finanziamento 181.49 M655 K195.88 M151.51 M 145.91 M Liquidità libera -131.83 M-165.41 M-122.86 M-167.09 M -158.74 M

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

PRME

Financials

Prime Medicine, Inc. - Common Stock

Notizie

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Prime Medicine nomina Svetlana Makhni come direttore finanziario

Prime Medicine nomina Svetlana Makhni direttore finanziario

Prime Medicine nomina Svetlana Makhni come CFO

Prime Drink Group annuncia posizionamento privato fino a 4 milioni di dollari canadesi

Prime Medicine, Inc. (PRME) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Citizens conferma il rating su Prime Medicine per il percorso PM359

Citizens reiterates Prime Medicine stock rating on PM359 pathway

Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates